Logotype for thyssenkrupp nucera AG & Co

thyssenkrupp nucera (NCH2) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for thyssenkrupp nucera AG & Co

Q3 2026 earnings summary

12 Aug, 2026

Executive summary

  • Delivered a solid quarter with strong performance in the chlor-alkali segment, robust project execution, and a healthy sales pipeline, including major new orders from China and successful projects in Brazil and the US.

  • Advanced green hydrogen projects with a major long-term service agreement in Spain, a strategic partnership with BHEL in India, and the Neom project nearing completion.

  • Regulatory and funding frameworks in the EU, India, and Japan are driving green hydrogen demand, supporting a substantial project pipeline and future growth.

  • Strategic decision to halt in-house SOEC stack production due to insufficient short-term market readiness, resulting in a one-time EBIT impact and future cost savings.

  • Order intake nearly doubled year-over-year in the first nine months, driven by strong growth in both green hydrogen and chlor-alkali segments.

Financial highlights

  • Q3 order intake reached EUR 81 million, up 29% year-on-year; nine-month order intake nearly doubled to EUR 471 million.

  • Q3 sales declined 21% year-on-year to EUR 145 million; green hydrogen sales fell to EUR 36 million, while chlor-alkali sales rose 34% to EUR 109 million.

  • Nine-month group sales declined 47% year-on-year to EUR 354 million, mainly due to maturing green hydrogen projects.

  • Q3 EBIT was stable at EUR -2 million; nine-month EBIT was EUR -69 million, impacted by EUR 50 million in one-time project costs.

  • Net financial assets stood at EUR 627 million at end of June 2026, reflecting a strong balance sheet.

Outlook and guidance

  • Updated FY order intake guidance to EUR 550–670 million, narrowing the previous range.

  • Group sales expected at EUR 450–500 million; EBIT forecast revised to EUR -105 to -75 million due to SOEC impairments.

  • Green hydrogen sales expected at EUR 100–130 million; EBIT for the segment at EUR -155 to -135 million.

  • Chlor-alkali sales guided at EUR 320–400 million, EBIT at EUR 45–65 million, with expectations to reach the midpoint.

  • Anticipates a new green hydrogen project award within calendar year 2026.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more